The Adrenaline Paradox episode artwork

EPISODE · May 15, 2026 · 5 MIN

The Adrenaline Paradox

from ALS Insights – Life Support Institute of Australia · host Life Support Institute of Australia

Adrenaline (epinephrine) is a key drug in ANZCOR-aligned ALS for cardiac arrest — but what's really happening? Its alpha-adrenergic effects cause vasoconstriction, boosting coronary and cerebral perfusion to improve ROSC chances. The beta-adrenergic side ramps up heart rate and contractility... which can spike myocardial oxygen demand and contribute to poorer neurological outcomes in survivors.We cover the basics: standard 1 mg dosing, timing in shockable rhythms, and why evidence shows ROSC gains but often no long-term neuro benefit — or even risks. Quick, practical insights for paramedics, nurses, and doctors.

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

NOW PLAYING

The Adrenaline Paradox

0:00 5:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ALS Insights – Life Support Institute of Australia?

This episode is 5 minutes long.

When was this ALS Insights – Life Support Institute of Australia episode published?

This episode was published on May 15, 2026.

Can I download this ALS Insights – Life Support Institute of Australia episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!